Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 13,158 shares (grant or award)
  3. 4 Other disposition President and CEO disposed of 56,332 shares (code )
  4. 4 Planned sale President and CEO sold 84,000 shares at an average $3.82 ($321,134)
  5. 4 Planned sale Chief Financial Officer sold 60,000 shares at an average $3.89 ($233,388)
  6. 4 Planned sale Chief Medical Officer sold 60,000 shares at an average $3.87 ($232,402)
  7. 4 Planned sale Chief Medical Officer sold 8,125 shares at $4.07 ($33,089)
  8. 4/A Open-market buy Director bought 5,500 shares at $3.55 ($19,514)
  9. 4/A Open-market buy Director bought 5,500 shares at $3.55 ($19,514)
  10. 4 Open-market buy Director bought 700 shares at $3.73 ($2,611)
  11. 4 Open-market buy Director bought 5,500 shares at $3.55 ($19,514)
  12. 4 Open-market buy Director bought 700 shares at $3.73 ($2,611)
  13. 4 Planned sale President and CEO sold 7,829 shares at $7.06 ($55,241)
  14. 4 Planned sale Chief Medical Officer sold 19,442 shares at $7.04 ($136,872)
  15. 4 Planned sale Director sold 24,499 shares at $7.04 ($172,424)
  16. 4 Open-market sale 10% owner sold 30,681 shares at $6.66 ($204,335)
  17. 4 Planned sale Director sold 28,210 shares at an average $6.28 ($177,208)
  18. 4 Planned sale Director sold 175,790 shares at an average $6.00 ($1,055,311)
  19. 4/A Open-market sale 10% owner sold 162,069 shares at an average $5.68 ($920,855)
  20. 4 Open-market sale 10% owner sold 150,000 shares at an average $5.68 ($851,700)

Page 2 of 39 · 776 filings